Juul Labs reaches $440 million settlement with state attorneys general

Sep.21.2022
Juul Labs reaches $440 million settlement with state attorneys general
Juul Labs settles for nearly $440 million with 32 state attorneys general for vaping-related youth harm.

Juul Labs has reached a legal settlement of nearly $440 million with 32 state attorneys general, as well as many other attorneys general from various states and regions across the United States. The settlement reflects efforts to abide by the 1998 Master Settlement Agreement which outlines the current state of tobacco in the United States.


Court documents reveal that the settlement funds will be paid out over the course of six to ten years, with a majority of the money going towards youth prevention programs for vaping and other state and local public and community health initiatives.


The Attorney General of Connecticut, William Tong, issued a statement claiming that he and his office "led the fight" to hold Juul accountable. Oregon Attorney General Ellen Rosenblum also stated that her office "led the fight." She said, "The social costs and public health consequences are enormous and devastating." Texas Attorney General Ken Paxton also stated that his department "led the fight." "When I launched this investigation more than two years ago, my goal was to ensure that JUUL was held accountable for any past wrongdoing and to ensure that they change direction to fully comply with future laws," Paxton said. Other attorneys general are still continuing their victory lap. But who really led the effort to reach a multi-state, multi-jurisdictional settlement with this electronic cigarette company once touted as the largest in the entire US market? Technically, Paxton, Rosenblum, and Tong led the coordinated interstate investigation with assistance from other AG offices. But the true leader behind it all was what's been called the moral panic machine of the US federal government, three US presidents, and several regulatory agencies.


According to a national news report by the state-run broadcaster, Juul is now required to pay this amount to compensate for promoting high-nicotine closed electronic cigarette devices and committing legal offenses that have contributed to the national youth vaping epidemic. The former Food and Drug Administration (FDA) commissioner appointed by former President Donald Trump, Scott Gottlieb, declared the youth vaping trend in 2018. Following this, Trump signed legislation to raise the minimum legal age for sales of all tobacco products nationwide from 18 to 21 years old.


It was under the leadership of Donald Trump that the FDA quashed its stance on simplifying the implementation of PMTA regulatory procedures, resulting in companies being unable to operate within expensive regulatory environments and ultimately being forced to shut down.


Prior to this, President Barack Obama signed the Tobacco Control Act which authorized pre-market approval of tobacco products and halted years of product innovation. This law also gave the FDA the power to regulate tobacco products without considering other harm reduction methods. President Joe Biden signed legislation targeting synthetic nicotine and other legal tools in an attempt to eliminate the entire product category of nicotine ENDS. All three presidents were appointed and supported by the FDA commissioner, a surgeon and the Secretary of Health and Human Services who debunked the claim that e-cigarettes are just as bad or worse than smoking.


The settlement behind Juul's settlement is the result of a short history. As stated in the settlement, Juul must abide by certain mandatory activities: not marketing its products to young people; absolutely not funding pilot programs to reduce the harm of its products; not depicting people under 35 years old in any promotional materials or collateral; not using cartoons in marketing; no paid product placements; not selling branded merchandise; banning the sale of unapproved e-cigarette flavors by the FDA; no feasible age verification measures on the landing page, which prevents access to the website; no unapproved nicotine statements by the FDA; no false nicotine content statements; no sponsorship or naming rights; advertising not permitted unless 85% of the audience of the outlet is adult viewers; no billboards; no public transportation ads; no social media ads claiming health benefits, only recommendations for consumers over 35 years old; no use of paid influencers; advertising not permitted to be directly targeted at consumers unless age-verified; and no free samples of Juul products.


The demands for a settlement are similar to those for a master settlement agreement and tobacco advertising regulations. While I do not oppose some measures in a settlement, what is disheartening is the underlying meaning behind it. The master settlement agreement and laws requiring the payment of tobacco taxes essentially created a funding source worth billions of dollars for federal, state, and local governments.


However, some of these states have not used the funds they received for future youth prevention and public health education, despite having departments and offices that are underfunded compared to other regions of the country.


Lindsey Stroud, Director of the Consumers’ Center for the right-wing taxpayer protection alliance, also made this point.


Instead, each state is seeking funding from a company.


In her column on right-wing political blog Townhall.com, the author wrote: "The state's spending on youth tobacco and e-cigarette prevention is so low that the funds seven states have secured from electronic cigarette manufacturers to settle with Juul will exceed the funds their states have invested in these programs over the past six years." The author, Stroud, noted in her column that the states investigating and settling with Juul have little or no funding from tobacco control programs, including those aimed at preventing youth from using e-cigarettes. "In fact, 2016 was the last year that the state spent any of its own money on preventing youth from using e-cigarettes, and Juul will be paying Connecticut $16.2 million," she said.


This is a standard for many countries involved in the entire solution. Over the past six years, Stroud has cited data she obtained from the "Smoke-Free Kid" movement, pointing out that the states in the agreement have only funded tobacco control education programs in the tens of millions. One can imagine that states claiming to protect public health through tobacco control measures would invest more funds from their general budgets or cash funds.


Many people point out that this is clearly a case of the company paying for the government's failure.


Statement:


This article is compiled from third-party information for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only for industry communication and research purposes.


Due to limitations in the translation skills, the translated article may not fully capture the intended meaning of the original text. Please refer to the original article for accuracy.


2FIRSTS remains fully aligned with the Chinese government's position on any domestic, Hong Kong, Macau, Taiwan, or international issues and statements.


Copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to remove it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09